Matches in Nanopublications for { ?s ?p "DDI between Dantrolene and Posaconazole - Posaconazole may increase the serum concentration of dantrolene by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of dantrolene if posaconazole is initiated, discontinued or dose changed. [drugbank_resource:DB01219_DB01263]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01219_DB01263 label "DDI between Dantrolene and Posaconazole - Posaconazole may increase the serum concentration of dantrolene by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of dantrolene if posaconazole is initiated, discontinued or dose changed. [drugbank_resource:DB01219_DB01263]" assertion.